Histopathology innovator raises $32m in funding round, looks to accelerate cancer research and drug discovery
HistoWiz, a US-based digital histopathology service company, recently announced the closing of a $32m Series A financing round.
HistoWiz, a US-based digital histopathology service company, recently announced the closing of a $32m Series A financing round.
Birmingham Biotech and the University of Birmingham have signed a licensing agreement for an anti-viral nasal spray against COVID-19.
Sanofi will invest up to $60m in equity in retinal gene therapy company Gyroscope Therapeutics.
Dutch stem cell company Neuroplast has announced positive Phase 1 results for its Neuro-Cells investigational stem cell treatment in patients suffering from Traumatic Spinal Cord Injury (TSCI).